Aspiration pneumonia. Recognizing and managing a potentially growing disorder

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Aspiration of foreign material into the lungs can lead to severe pneumonia.
• Initial lung injury is often mediated by inflammation, with infection playing a secondary role.
• Pathogen profiles vary significantly between community-acquired and hospital-acquired (nosocomial) aspiration pneumonia.

Purpose of the Study:

• To summarize the understanding of aspiration pneumonia, including its pathophysiology, causative agents, and management.
• To highlight the importance of empirical antibiotic therapy in severe cases.
• To emphasize tailoring antimicrobial treatment to specific patient and local epidemiological factors.

Main Methods:

• Review of current literature and treatment guidelines for aspiration pneumonia.
• Analysis of differences in bacterial pathogens based on acquisition setting (community vs. nosocomial).
• Discussion of the role of inflammatory mediators in initial lung injury.

Main Results:

• Aspiration pneumonia can cause hypoxemia, pulmonary infiltrates, fever, and leukocytosis.
• Mixed aerobic-anaerobic infections are common.
• Nosocomial aspiration pneumonia frequently involves enteric gram-negative bacilli and Staphylococcus aureus.

Conclusions:

• Prompt and appropriate empirical antibiotic therapy is vital for improving outcomes in severe aspiration pneumonia.
• Treatment decisions should consider patient characteristics, the context of aspiration, pneumonia severity, and local resistance data.
• Understanding the distinct microbial patterns in different settings is key to effective management.